Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates The following represents disclosure information provided by authors of this ...

Sponsored by: Diagnostica Stago, Inc. In clinical laboratory settings, coagulation factor tests are routinely conducted to identify inherited or acquired deficiencies in patients suspected of an ...

To update ASCO–College of American Pathologists (CAP) recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer. The Panel is aware that a new generation of antibody ...

When persistent joint pain strikes, the search for answers often leads to a crucial diagnostic tool: the rheumatoid factor test. This relatively quick blood analysis serves as a window into the immune ...

Co-Founder & CTO of Cymulate. Previously, Avihai was the Head of the Cyber Research Team at Avnet Cyber & Information Security. Automation is making its way into many aspects of cybersecurity testing ...

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Experienced ...

A new study led by Professor Laura Magee, has found that among pregnancies with clinical risk factors for pre-eclampsia or fetal growth restriction, measuring serum placental growth factor (PlGF) at ...

To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer ...